Health Condition 1: null- Patients with cancer who requires chemotherapy
Conditions
Interventions
Intervention1: Inj Iron Sucrose: Inj Iron Sucrose 500 mg in 250 ml 5% Dextrose Intravenous drip over 120 minutes Given twice (with cycle one and cycle two of chemotherapy.)
Control Intervention1: Oral
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with cancer requiring chemotherpy 2. Hemoglobin less than or equal to 12 3. Hypochromic RBC >10%, Transferrin Saturation 4. Age > 18 yrs 5. Written Informed Consent
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to iron therapy 2. Uncontrolled medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to determine the change in Hb before and after 2 cycles of chemotherapyTimepoint: From Baseline to the end of the 3 weeks after starting the second cycle of systemic chemotherapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess Quality of life of patients for the given study period 2. To assess need for packed transfusion requirements during the study.Timepoint: 1. Every 3 weekly for 3 cycles 2. Within 2 months | — |
Countries
India
Contacts
Public ContactDr Kumar Prabhash
CMC Vellore
Outcome results
None listed